Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to PANCREATIC CANCER

OBR Oncology

FDA Approves Irinotecan Liposome Combo in Metastatic Pancreatic Cancer

Hematology/Oncology February 20th 2024

NEJM Evidence

Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer

Oncology, Medical February 5th 2024

Medical Professionals Reference (MPR)

FDA Drug Approval Decisions Expected in February 2024

Hematology/Oncology January 22nd 2024

Mayo Clinic

Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023

Gastroenterology November 6th 2023

Mayo Clinic

Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023 (CME)

Oncology, Medical July 18th 2023

Cancer Therapy Advisor

Neoadjuvant FOLFIRINOX Does Not Improve OS in Resectable Pancreatic Cancer

Oncology, Medical June 12th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form